Featured Jobs
|
MAP Retirement
|
|
Regional Vice President, Sales MAP Retirement
|
|
DWC - The 401(k) Experts
|
|
Sentinel Group
|
|
Pattison Pension
|
|
MAP Retirement
|
|
Plan Administrator, Defined Benefit & Cash Balance The Pension Source
|
|
Retirement Relationship Manager MAP Retirement
|
|
BPAS
|
|
Strategic Retirement Plan Consultant Retirement Plan Consultants
|
|
Defined Benefit Plan Consultant/Actuarial Analyst Sentinel Group
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Key Driver of High Rx Spending: Brand-Name Drug Prices
The Commonwealth Fund 
Nov. 18, 2021 "High U.S. drug prices are a financial strain for patients, employers, and state and federal governments. [A series of charts presents] the findings from a number of studies on prescription drug costs and spending in the United States with other high-income countries to reveal the main culprit: high U.S. prices for brand-name drugs." |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |